BUY TCS and Glenmark Pharma: Siddarth Bhamre, InCred Equities
Siddarth Bhamre, Director - Alternate Investment & Research at InCred Equities has suggested two BUY Calls for short term investors. Indian markets are trading around all time highs for major indices. US and European stocks closed positive last week and the sentiment in global markets is positive. With strong earnings expected in the upcoming quarter, stocks could remain at elevated valuations. While many market participants are concerned about high stock valuations, corrections in markets have been brief and have been followed by quick recovery.
Bhamre has suggested BUY Call for technology major TCS with a stop loss at Rs 3,385 for a target of Rs 3,610. Technology and pharmaceutical companies have been among investor favorites after last year’s lockdowns.
Bhamre has suggested BUY Call for pharmaceutical major Glenmark Pharma with a stop loss at Rs 532 for a target of Rs 645.
All trades should be carried out with strict Stop Loss. In case the trade doesn’t happen as per expectations, it is good to exit the trade if the call is in profit. TopNews will review performance of trading calls by the end of the trading session.